ProQR Therapeutics
PRQR
PRQR
44 hedge funds and large institutions have $161M invested in ProQR Therapeutics in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
45% less call options, than puts
Call options by funds: $80K | Put options by funds: $146K
46% less capital invested
Capital invested by funds: $299M → $161M (-$138M)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Holders
44
Holding in Top 10
2
Calls
$80K
Puts
$146K
Top Buyers
| 1 | +$2.63M | |
| 2 | +$1.38M | |
| 3 | +$1.11M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$677K |
| 5 |
JPMorgan Chase & Co
New York
|
+$485K |
Top Sellers
| 1 | -$2.52M | |
| 2 | -$2.43M | |
| 3 | -$1.59M | |
| 4 |
Millennium Management
New York
|
-$1.55M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$786K |